Genomic data and prostate cancer risk classification: an update

Three different molecular tests have been validated as providing useful data that can help a man and his doctors to come to decisions about the management and treatment of localized prostate cancer. … READ MORE …

More reports from the EAU “Update on Prostate Cancer”

Dr. Zachary Klaassen and UroToday have provided us with four more interesting summaries of presentations by faculty at the European Association for Urology (EAU)’s meeting in Vienna last weekend. … READ MORE …

How close are we really to “precision medicine” for cancer care?

A newly published paper in the journal JCO Precision Oncology confirms what many of us may have suspected — that the practical application of somatic tissue testing to clinical decision-making was low prior to 2015 . … READ MORE …

SHIVA trial studying response to molecular targeting strategy for drug therapy

At the upcoming meeting of the European Cancer Congress (ECC2013), starting on Friday, September 27 in Amsterdam, The Netherlands, Dr. Christophe Le Tourneau, Head of the Phase I Program at the Institut Curie, Paris, France, will give attendees an initial report on progress of the so-called SHIVA trial. … READ MORE …